Position in FATE
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$158,769
+$14,944 QoQ
Shares Held
132,308
-9.8% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 22.07047192913505.ToString("F0")%
Shared 0.ToString("F0")%
None 77.92952807086495.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. FATE ranks #212 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in FATE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $158,769 | 132,308 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $143,825 | 146,761 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $194,148 | 154,086 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $174,560 | 155,858 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $118,695 | 150,248 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $262,633 | 159,172 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $549,493 | 156,998 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $524,803 | 160,001 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,058,251 | 144,176 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $524,852 | 140,335 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $297,525 | 140,342 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $660,250 | 138,708 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $664,329 | 116,549 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,149,664 | 113,941 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,473,010 | 110,353 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,512,146 | 101,378 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,465,340 | 89,382 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $5,185,390 | 88,624 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $5,433,458 | 91,673 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,773,259 | 89,564 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $7,381,501 | 89,527 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $8,662,446 | 95,265 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $3,573,078 | 89,394 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,530,087 | 102,888 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,954,035 | 87,980 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||